By data results corroboration, the authors [60,61], in fact, demonstrated the danger coming from the dual role (stimulator and inhibitor) of p53 and its mutant (proved present in 50% of all types of cancer in humans) on VEGF. The gene discussed is TP53; the disease is cancer.